Optometry

Top Story

FDA recalls Visibly online refraction test

FDA recalls Visibly online refraction test
August 23, 2019

OSN cover story focuses on ophthalmic drug shortages

August 24, 2019
Some features in the Aug. 25 issue of Ocular Surgery News focus on ophthalmic drug shortages and the use of generic drugs in such shortages. Here are some of the…
In the Journals

Wet AMD gene therapy well tolerated through 3 years

August 23, 2019
Patients with wet age-related macular degeneration who responded well to rAAV.sFLT-1 subretinal gene therapy at 1 year maintained that response through 3 years, but the…

ONL raises $3 million in financing to advance Fas inhibitor study

August 23, 2019
ONL Therapeutics will begin a first-in-human study of its Fas inhibitor for retinal diseases following the completion of $3 million in convertible note financing…

Iconic, Novartis sign ophthalmology option agreement

August 23, 2019
Iconic Therapeutics has signed an agreement with Novartis that will give Novartis an option on Iconic’s ophthalmology program, according to a press release. Iconic…
More Headlines »
CME CE

Visualizing the Latest In DME Management: Implementing Novel Treatment Strategies to Improve Patient Outcomes

Supported by an educational grant from Allergan Inc.

Despite the critical role of vascular endothelial growth factor (VEGF) inhibitors in managing patients with diabetic…
More »
Video
Meeting News

VIDEO: Bi-Blade efficiency compares favorably with single port cutter

August 15, 2019
More »
Resource Centers
Optometry's Meeting

Optometry's Meeting

Video
Meeting News

VIDEO: Aflibercept ‘greatly reduced’ rates of vision-threatening complications in diabetic retinopathy

July 30, 2019
More »
Current Issues
View the Current Issue
Primary Care Optometry News